You have 9 free searches left this month | for more free features.

Condition

Adenocarcinoma of Lung (1)

NSCLC, Recurrent (1)

Ovarian Cancer (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

ARCAGY/ GINECO GROUP (1)

Royal Marsden NHS Foundation Trust (1)

Collaborator

Boehringer Ingelheim (1)

Celgene (1)

Intervention

placebo (2)

vargatef (2)

abraxane (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

vargatef

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ovarian Cancer Trial in France (vargatef, )

Completed

Ovarian Cancer

vargatef
placebo

Angers, France
+35 more

Jan 13, 2023

NSCLC, Recurrent, Adenocarcinoma of Lung Trial (Vargatef, Abraxane, )

Withdrawn

NSCLC, Recurrent
Adenocarcinoma of Lung

Vargatef
+2 more

(no location specified)

Nov 20, 2020